Format

Send to

Choose Destination
See comment in PubMed Commons below
Gynecol Oncol. 2016 Jun;141(3):543-549. doi: 10.1016/j.ygyno.2016.04.006. Epub 2016 Apr 19.

Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society's Study of Cancer Survivors - I.

Author information

1
Yale Cancer Center, New Haven, CT, United States; Yale School of Public Health, New Haven, CT, United States. Electronic address: yang.zhou@yale.edu.
2
Yale Cancer Center, New Haven, CT, United States; Yale School of Public Health, New Haven, CT, United States.
3
Yale Cancer Center, New Haven, CT, United States; School of Nursing, Yale University, New Haven, CT, United States.
4
School of Nursing, Yale University, New Haven, CT, United States.
5
Yale School of Public Health, New Haven, CT, United States.
6
Behavioral Research Center, American Cancer Society, Atlanta, GA, United States.

Abstract

OBJECTIVE:

There are limited data on outcomes and predictors of health-related quality of life (HRQOL) of ovarian cancer survivors. Therefore, we examined the trajectory and predictors of HRQOL one- and two-years post-diagnosis in this population.

METHODS:

365 ovarian cancer survivors, a subset of participants in the longitudinal American Cancer Society's Study of Cancer Survivors-I, completed questionnaires at one-year post-diagnosis on sociodemographics, clinical factors, and HRQOL (SF-36). 284 women had HRQOL data at two-years post-diagnosis. In this secondary data analysis, we examined HRQOL at both time points, changes in HRQOL and predictors of HRQOL with univariate and multivariate linear regression.

RESULTS:

Mean mental and physical HRQOL scores one-year post-diagnosis were 49.37 (SD±11.59) and 45.96 (SD±10.89), respectively. Older age, lower income, higher disease stage, more comorbidities and greater symptom burden were associated with poorer physical functioning one year post-diagnosis. Younger age, higher stage, having an existing mental health issue, greater symptom burden, and not receiving chemotherapy were associated with poorer mental functioning. Disease recurrence between one- and two-years post-diagnosis and greater symptom burden were predictors of declining physical functioning from one- to two-years post-diagnosis. Mental functioning did not change significantly between assessments.

CONCLUSIONS:

Overall mental and physical functioning of these ovarian cancer survivors was similar to the general population. However, lower HRQOL was associated with a number of variables, including disease recurrence, treatment status, symptom burden, age, and number of comorbidities. These findings can help health care providers identify survivors who may benefit from relevant interventions.

KEYWORDS:

Ovarian cancer; Quality of life; Survivors

PMID:
27072805
PMCID:
PMC4913461
DOI:
10.1016/j.ygyno.2016.04.006
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center